 |
OmniSpirant Therapeutics
Last updated: October 29, 2025
Founder Gerry McCauley
Ireland | Funding: €13.4M (+)
Website: https://www.omnispirant.com
Developing first in class regenerative gene therapies. Proprietary OmniSomes technology uses bioengineered stem cell extracellular vesicles (exosomes) as novel delivery vehicles for RNA based advanced therapeutics with regenerative medicine properties.
Website: https://www.omnispirant.com
Developing first in class regenerative gene therapies. Proprietary OmniSomes technology uses bioengineered stem cell extracellular vesicles (exosomes) as novel delivery vehicles for RNA based advanced therapeutics with regenerative medicine properties.
